Form D · Biotechnology

Entvantage Diagnostic Associates LLC

Austin, TX · CIK 0001820856

Offering snapshot reported Jan 20, 2021 · SEC filing

Reported sold
$1.14M
Offering amount: $1.32M
Investors reported
20
Form D · investor count
Minimum accepted
$15K
Reported outside-investor minimum
First sale
Jul 29, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$570K$1.14MAug 12, 2020: $715,000.00Aug 12, 2020Jan 20, 2021: $1,140,000.00Jan 20, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$715,000 → $1,140,000
  • Reported investors11 → 20
  • Minimum accepted$10,000 → $15,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 20, 2021Amendment$1,140,000$425,000vs Aug 12, 202020SEC filing
Aug 12, 2020Initial$715,000No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-373033
None paid

Source: Form D, filed Jan 20, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard John Hawkins Director
Joseph Stephen Skraba Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4200 Marathon Blvd. Suite 200
Austin, TX, 78756